UChicago Microbiome Startups Come Together Under New Company to Amplify Results
32 Biosciences is advancing field-defining research to build clinically useful, validated, precision tools to diagnose and correct Dysbiosis (microbiome imbalance). Two University of Chicago startups are now operating under a parent company, 32 Biosciences – with a shared… Keep reading